This company has been marked as potentially delisted and may not be actively trading. Soaring Eagle Acquisition (SRNG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock SRNG vs. ADMA, PCVX, KRYS, ACLX, SWTX, CRSP, ALVO, SRRK, IMVT, and IBRXShould you be buying Soaring Eagle Acquisition stock or one of its competitors? The main competitors of Soaring Eagle Acquisition include ADMA Biologics (ADMA), Vaxcyte (PCVX), Krystal Biotech (KRYS), Arcellx (ACLX), SpringWorks Therapeutics (SWTX), CRISPR Therapeutics (CRSP), Alvotech (ALVO), Scholar Rock (SRRK), Immunovant (IMVT), and ImmunityBio (IBRX). Soaring Eagle Acquisition vs. ADMA Biologics Vaxcyte Krystal Biotech Arcellx SpringWorks Therapeutics CRISPR Therapeutics Alvotech Scholar Rock Immunovant ImmunityBio ADMA Biologics (NASDAQ:ADMA) and Soaring Eagle Acquisition (NASDAQ:SRNG) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, community ranking, earnings, dividends, analyst recommendations, valuation and profitability. Do analysts prefer ADMA or SRNG? ADMA Biologics currently has a consensus target price of $24.25, suggesting a potential upside of 18.70%. Given ADMA Biologics' stronger consensus rating and higher probable upside, research analysts clearly believe ADMA Biologics is more favorable than Soaring Eagle Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ADMA Biologics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Soaring Eagle Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in ADMA or SRNG? 75.7% of ADMA Biologics shares are held by institutional investors. Comparatively, 41.2% of Soaring Eagle Acquisition shares are held by institutional investors. 3.5% of ADMA Biologics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor ADMA or SRNG? ADMA Biologics received 415 more outperform votes than Soaring Eagle Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformADMA BiologicsOutperform Votes41572.05% Underperform Votes16127.95% Soaring Eagle AcquisitionN/AN/A Does the media favor ADMA or SRNG? In the previous week, ADMA Biologics had 7 more articles in the media than Soaring Eagle Acquisition. MarketBeat recorded 7 mentions for ADMA Biologics and 0 mentions for Soaring Eagle Acquisition. ADMA Biologics' average media sentiment score of 1.32 beat Soaring Eagle Acquisition's score of 0.20 indicating that ADMA Biologics is being referred to more favorably in the media. Company Overall Sentiment ADMA Biologics Positive Soaring Eagle Acquisition Neutral Is ADMA or SRNG more profitable? ADMA Biologics has a net margin of 17.80% compared to Soaring Eagle Acquisition's net margin of 0.00%. ADMA Biologics' return on equity of 53.20% beat Soaring Eagle Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets ADMA Biologics17.80% 53.20% 26.07% Soaring Eagle Acquisition N/A N/A N/A Which has preferable valuation & earnings, ADMA or SRNG? Soaring Eagle Acquisition has lower revenue, but higher earnings than ADMA Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioADMA Biologics$459.38M10.62-$28.24M$0.8524.04Soaring Eagle AcquisitionN/AN/AN/AN/AN/A SummaryADMA Biologics beats Soaring Eagle Acquisition on 13 of the 13 factors compared between the two stocks. Get Soaring Eagle Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNG vs. The Competition Export to ExcelMetricSoaring Eagle AcquisitionBiological Products, Except Diagnostic IndustryEnergy SectorNASDAQ ExchangeMarket Cap$1.50B$3.04B$7.46B$8.48BDividend YieldN/A1.60%11.10%4.19%P/E RatioN/A30.9153.3619.73Price / SalesN/A445.5625,125.77144.51Price / CashN/A168.6835.7234.64Price / BookN/A3.323.524.55Net IncomeN/A-$72.17M$4.33B$248.13M Soaring Eagle Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNGSoaring Eagle AcquisitionN/A$6.95-4.1%N/A+1,215.0%$1.50BN/A0.00N/AADMAADMA Biologics2.7985 of 5 stars$20.42+1.3%$24.25+18.8%+109.1%$4.87B$459.38M72.93530Positive NewsPCVXVaxcyte3.0233 of 5 stars$32.54-4.2%$136.50+319.5%-53.6%$4.20BN/A-7.07160Positive NewsGap UpKRYSKrystal Biotech4.8406 of 5 stars$125.05-0.2%$211.13+68.8%-20.6%$3.61B$333.45M41.82210ACLXArcellx2.2529 of 5 stars$63.92-2.0%$111.33+74.2%+22.3%$3.52B$76.81M-90.0380Positive NewsSWTXSpringWorks Therapeutics1.6382 of 5 stars$46.48+0.5%$52.57+13.1%+12.7%$3.50B$219.67M-13.36230Positive NewsHigh Trading VolumeCRSPCRISPR Therapeutics3.2377 of 5 stars$36.86-1.8%$71.75+94.7%-32.9%$3.18B$35M-8.43473Positive NewsInsider TradeAnalyst RevisionALVOAlvotech2.3857 of 5 stars$10.28+3.4%$18.00+75.1%-16.6%$3.10B$585.60M-5.564Short Interest ↓SRRKScholar Rock4.255 of 5 stars$30.00-1.5%$42.67+42.2%+210.2%$2.85B$33.19M-12.77140Positive NewsInsider TradeGap DownIMVTImmunovant2.2463 of 5 stars$14.46-0.7%$38.33+165.1%-41.4%$2.46BN/A-5.52120Positive NewsEarnings ReportUpcoming EarningsAnalyst RevisionIBRXImmunityBio2.2752 of 5 stars$2.53-5.6%$12.25+384.2%-58.4%$2.23B$31.22M-2.75590Options VolumeGap Up Related Companies and Tools Related Companies ADMA Alternatives PCVX Alternatives KRYS Alternatives ACLX Alternatives SWTX Alternatives CRSP Alternatives ALVO Alternatives SRRK Alternatives IMVT Alternatives IBRX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRNG) was last updated on 6/2/2025 by MarketBeat.com Staff From Our PartnersThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soaring Eagle Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soaring Eagle Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
